ULTRALIFE CORP (ULBI) Fundamental Analysis & Valuation

NASDAQ:ULBI • US9038991025

5.25 USD
-0.02 (-0.38%)
Last: Mar 6, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ULBI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

Overall ULBI gets a fundamental rating of 5 out of 10. We evaluated ULBI against 91 industry peers in the Electrical Equipment industry. ULBI has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on ULBI. This makes ULBI very considerable for value investing!


Dividend Valuation Growth Profitability Health

5

1. ULBI Profitability Analysis

1.1 Basic Checks

  • In the past year ULBI was profitable.
  • ULBI had a positive operating cash flow in the past year.
  • In multiple years ULBI reported negative net income over the last 5 years.
  • Of the past 5 years ULBI 4 years had a positive operating cash flow.
ULBI Yearly Net Income VS EBIT VS OCF VS FCFULBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

  • With a decent Return On Assets value of 0.77%, ULBI is doing good in the industry, outperforming 67.03% of the companies in the same industry.
  • The Return On Equity of ULBI (1.25%) is better than 68.13% of its industry peers.
  • ULBI has a better Return On Invested Capital (3.23%) than 68.13% of its industry peers.
  • ULBI had an Average Return On Invested Capital over the past 3 years of 3.14%. This is significantly below the industry average of 9.57%.
  • The last Return On Invested Capital (3.23%) for ULBI is above the 3 year average (3.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.77%
ROE 1.25%
ROIC 3.23%
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ULBI Yearly ROA, ROE, ROICULBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

  • ULBI has a better Profit Margin (0.92%) than 69.23% of its industry peers.
  • In the last couple of years the Profit Margin of ULBI has declined.
  • The Operating Margin of ULBI (4.20%) is better than 69.23% of its industry peers.
  • ULBI's Operating Margin has been stable in the last couple of years.
  • ULBI's Gross Margin of 23.89% is in line compared to the rest of the industry. ULBI outperforms 49.45% of its industry peers.
  • ULBI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.2%
PM (TTM) 0.92%
GM 23.89%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
ULBI Yearly Profit, Operating, Gross MarginsULBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ULBI Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ULBI is destroying value.
  • Compared to 1 year ago, ULBI has more shares outstanding
  • ULBI has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, ULBI has a worse debt to assets ratio.
ULBI Yearly Shares OutstandingULBI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ULBI Yearly Total Debt VS Total AssetsULBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of 1.73, we must say that ULBI is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.73, ULBI perfoms like the industry average, outperforming 58.24% of the companies in the same industry.
  • The Debt to FCF ratio of ULBI is 5.62, which is a neutral value as it means it would take ULBI, 5.62 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 5.62, ULBI is doing good in the industry, outperforming 72.53% of the companies in the same industry.
  • A Debt/Equity ratio of 0.34 indicates that ULBI is not too dependend on debt financing.
  • ULBI's Debt to Equity ratio of 0.34 is fine compared to the rest of the industry. ULBI outperforms 60.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 5.62
Altman-Z 1.73
ROIC/WACC0.45
WACC7.17%
ULBI Yearly LT Debt VS Equity VS FCFULBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • A Current Ratio of 2.99 indicates that ULBI has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.99, ULBI is in the better half of the industry, outperforming 78.02% of the companies in the same industry.
  • A Quick Ratio of 1.42 indicates that ULBI should not have too much problems paying its short term obligations.
  • The Quick ratio of ULBI (1.42) is better than 62.64% of its industry peers.
Industry RankSector Rank
Current Ratio 2.99
Quick Ratio 1.42
ULBI Yearly Current Assets VS Current LiabilitesULBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ULBI Growth Analysis

3.1 Past

  • ULBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -77.78%.
  • ULBI shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.31% yearly.
  • The Revenue has grown by 12.94% in the past year. This is quite good.
  • The Revenue has been growing by 9.02% on average over the past years. This is quite good.
EPS 1Y (TTM)-77.78%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-450%
Revenue 1Y (TTM)12.94%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%21.51%

3.2 Future

  • Based on estimates for the next years, ULBI will show a very strong growth in Earnings Per Share. The EPS will grow by 43.60% on average per year.
  • The Revenue is expected to grow by 18.34% on average over the next years. This is quite good.
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ULBI Yearly Revenue VS EstimatesULBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ULBI Yearly EPS VS EstimatesULBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

7

4. ULBI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 37.50, which means the current valuation is very expensive for ULBI.
  • Based on the Price/Earnings ratio, ULBI is valued a bit cheaper than the industry average as 69.23% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 26.29. ULBI is valued slightly more expensive when compared to this.
  • ULBI is valuated cheaply with a Price/Forward Earnings ratio of 5.53.
  • Based on the Price/Forward Earnings ratio, ULBI is valued cheaper than 97.80% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.60, ULBI is valued rather cheaply.
Industry RankSector Rank
PE 37.5
Fwd PE 5.53
ULBI Price Earnings VS Forward Price EarningsULBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ULBI is valued cheaper than 95.60% of the companies in the same industry.
  • ULBI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ULBI is cheaper than 98.90% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.77
EV/EBITDA 9.73
ULBI Per share dataULBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • ULBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ULBI's earnings are expected to grow with 43.60% in the coming years.
PEG (NY)0.55
PEG (5Y)11.35
EPS Next 2Y43.6%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ULBI Dividend Analysis

5.1 Amount

  • No dividends for ULBI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ULBI Fundamentals: All Metrics, Ratios and Statistics

ULTRALIFE CORP

NASDAQ:ULBI (3/6/2026, 8:00:02 PM)

5.25

-0.02 (-0.38%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-18
Earnings (Next)03-10
Inst Owners72.37%
Inst Owner Change-1.44%
Ins Owners3.2%
Ins Owner Change0.58%
Market Cap87.41M
Revenue(TTM)186.53M
Net Income(TTM)1.72M
Analysts82.86
Price TargetN/A
Short Float %0.56%
Short Ratio2.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-91.09%
Min EPS beat(2)-131.19%
Max EPS beat(2)-50.98%
EPS beat(4)0
Avg EPS beat(4)-72.67%
Min EPS beat(4)-131.19%
Max EPS beat(4)-15.03%
EPS beat(8)3
Avg EPS beat(8)-15.66%
EPS beat(12)5
Avg EPS beat(12)43.11%
EPS beat(16)7
Avg EPS beat(16)38.76%
Revenue beat(2)0
Avg Revenue beat(2)-13.21%
Min Revenue beat(2)-19.77%
Max Revenue beat(2)-6.65%
Revenue beat(4)2
Avg Revenue beat(4)-3.82%
Min Revenue beat(4)-19.77%
Max Revenue beat(4)7.48%
Revenue beat(8)5
Avg Revenue beat(8)-1.68%
Revenue beat(12)7
Avg Revenue beat(12)2.25%
Revenue beat(16)10
Avg Revenue beat(16)3.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 37.5
Fwd PE 5.53
P/S 0.47
P/FCF 9.77
P/OCF 6.97
P/B 0.64
P/tB 1.28
EV/EBITDA 9.73
EPS(TTM)0.14
EY2.67%
EPS(NY)0.95
Fwd EY18.07%
FCF(TTM)0.54
FCFY10.24%
OCF(TTM)0.75
OCFY14.35%
SpS11.2
BVpS8.24
TBVpS4.12
PEG (NY)0.55
PEG (5Y)11.35
Graham Number5.1
Profitability
Industry RankSector Rank
ROA 0.77%
ROE 1.25%
ROCE 4.15%
ROIC 3.23%
ROICexc 3.4%
ROICexgc 5.52%
OM 4.2%
PM (TTM) 0.92%
GM 23.89%
FCFM 4.8%
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)5.27%
ROICexgc(5y)N/A
ROCE(3y)4.03%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y2.06%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.19%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
F-Score3
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 5.62
Debt/EBITDA 3.52
Cap/Depr 66.95%
Cap/Sales 1.93%
Interest Coverage 250
Cash Conversion 95.05%
Profit Quality 521.01%
Current Ratio 2.99
Quick Ratio 1.42
Altman-Z 1.73
F-Score3
WACC7.17%
ROIC/WACC0.45
Cap/Depr(3y)49.8%
Cap/Depr(5y)66.84%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.78%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-450%
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.94%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%21.51%
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.81%
EBIT growth 3YN/A
EBIT growth 5Y8.76%
EBIT Next Year101.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3629.58%
FCF growth 3Y113.07%
FCF growth 5YN/A
OCF growth 1Y506.14%
OCF growth 3Y56.62%
OCF growth 5YN/A

ULTRALIFE CORP / ULBI FAQ

What is the ChartMill fundamental rating of ULTRALIFE CORP (ULBI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ULBI.


What is the valuation status for ULBI stock?

ChartMill assigns a valuation rating of 7 / 10 to ULTRALIFE CORP (ULBI). This can be considered as Undervalued.


Can you provide the profitability details for ULTRALIFE CORP?

ULTRALIFE CORP (ULBI) has a profitability rating of 5 / 10.


What are the PE and PB ratios of ULTRALIFE CORP (ULBI) stock?

The Price/Earnings (PE) ratio for ULTRALIFE CORP (ULBI) is 37.5 and the Price/Book (PB) ratio is 0.64.


What is the expected EPS growth for ULTRALIFE CORP (ULBI) stock?

The Earnings per Share (EPS) of ULTRALIFE CORP (ULBI) is expected to grow by 68.52% in the next year.